These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 19487287

  • 1. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
    Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA.
    Cancer Res; 2009 Jun 01; 69(11):4708-15. PubMed ID: 19487287
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
    Chai CY, Chen WT, Hung WC, Kang WY, Huang YC, Su YC, Yang CH.
    J Clin Pathol; 2008 May 01; 61(5):658-64. PubMed ID: 17908805
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
    Theodoropoulos VE, Lazaris AC, Kastriotis I, Spiliadi C, Theodoropoulos GE, Tsoukala V, Patsouris E, Sofras F.
    BJU Int; 2005 Feb 01; 95(3):425-31. PubMed ID: 15679808
    [Abstract] [Full Text] [Related]

  • 4. Angiogenesis and prostate cancer: identification of a molecular progression switch.
    Huss WJ, Hanrahan CF, Barrios RJ, Simons JW, Greenberg NM.
    Cancer Res; 2001 Mar 15; 61(6):2736-43. PubMed ID: 11289156
    [Abstract] [Full Text] [Related]

  • 5. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model.
    Cheng L, Zhang S, Sweeney CJ, Kao C, Gardner TA, Eble JN.
    Anticancer Res; 2004 Mar 15; 24(4):2135-40. PubMed ID: 15330153
    [Abstract] [Full Text] [Related]

  • 6. The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue.
    Lekas A, Lazaris AC, Deliveliotis C, Chrisofos M, Zoubouli C, Lapas D, Papathomas T, Fokitis I, Nakopoulou L.
    Anticancer Res; 2006 Mar 15; 26(4B):2989-93. PubMed ID: 16886625
    [Abstract] [Full Text] [Related]

  • 7. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
    Fukuda H, Tsuchiya N, Narita S, Kumazawa T, Horikawa Y, Inoue T, Saito M, Yuasa T, Matsuura S, Satoh S, Ogawa O, Habuchi T.
    Oncol Rep; 2007 Nov 15; 18(5):1155-63. PubMed ID: 17914566
    [Abstract] [Full Text] [Related]

  • 8. Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy.
    Shariat SF, Anwuri VA, Lamb DJ, Shah NV, Wheeler TM, Slawin KM.
    J Clin Oncol; 2004 May 01; 22(9):1655-63. PubMed ID: 15117988
    [Abstract] [Full Text] [Related]

  • 9. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V, Mukunyadzi P, Dennis RA, Siegel ER, Johnson DE, Kohli M.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [Abstract] [Full Text] [Related]

  • 10. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
    Sun HC, Qiu ZJ, Liu J, Sun J, Jiang T, Huang KJ, Yao M, Huang C.
    Int J Oncol; 2007 Jun 15; 30(6):1359-67. PubMed ID: 17487356
    [Abstract] [Full Text] [Related]

  • 11. Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands.
    Monsef N, Helczynski L, Lundwall A, Påhlman S, Anders-Bjartell.
    Prostate; 2007 Aug 01; 67(11):1219-29. PubMed ID: 17562539
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X, Yang D, Hu J, Hao X, Gao J, Mao Z.
    Anticancer Res; 2008 Aug 01; 28(3A):1659-66. PubMed ID: 18630523
    [Abstract] [Full Text] [Related]

  • 13. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
    Yu ZT, Zhao HF, Shang XB.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 16; 88(35):2465-9. PubMed ID: 19080625
    [Abstract] [Full Text] [Related]

  • 14. Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.
    Korkolopoulou P, Patsouris E, Konstantinidou AE, Pavlopoulos PM, Kavantzas N, Boviatsis E, Thymara I, Perdiki M, Thomas-Tsagli E, Angelidakis D, Rologis D, Sakkas D.
    Neuropathol Appl Neurobiol; 2004 Jun 16; 30(3):267-78. PubMed ID: 15175080
    [Abstract] [Full Text] [Related]

  • 15. Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach.
    Takahashi R, Tanaka S, Hiyama T, Ito M, Kitadai Y, Sumii M, Haruma K, Chayama K.
    Oncol Rep; 2003 Jun 16; 10(4):797-802. PubMed ID: 12792726
    [Abstract] [Full Text] [Related]

  • 16. Expression of hypoxia-inducible factor-1 alpha and its prognostic significance in small-sized adenocarcinomas of the lung.
    Enatsu S, Iwasaki A, Shirakusa T, Hamasaki M, Nabeshima K, Iwasaki H, Kuroki M, Kuroki M.
    Eur J Cardiothorac Surg; 2006 Jun 16; 29(6):891-5. PubMed ID: 16675263
    [Abstract] [Full Text] [Related]

  • 17. Expression of hypoxia inducible factor-1 alpha in matched hormone naive and castrate resistant prostate cancer specimens.
    Elsberger B, Lankston L, Orange C, Underwood MA, Edwards J.
    Cancer Biomark; 2006 Jun 16; 8(1):1-9. PubMed ID: 21896985
    [Abstract] [Full Text] [Related]

  • 18. The expression of vascular endothelial growth factor is associated with the risk of cancer progression after radical prostatectomy.
    Peyromaure M, Camparo P, Badoual C, Descazeaud A, Dinh-Xuan AT.
    BJU Int; 2007 May 16; 99(5):1150-3. PubMed ID: 17437444
    [Abstract] [Full Text] [Related]

  • 19. Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases.
    Cheng J, Slavin RE, Gallagher JA, Zhu G, Biehl TR, Swanstrom LL, Hansen PD.
    J Hepatobiliary Pancreat Surg; 2004 May 16; 11(3):164-70. PubMed ID: 15235888
    [Abstract] [Full Text] [Related]

  • 20. Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia.
    Lekas AG, Lazaris AC, Chrisofos M, Papatsoris AG, Lappas D, Patsouris E, Deliveliotis C.
    Urology; 2006 Aug 16; 68(2):436-41. PubMed ID: 16904480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.